Geode Capital Management, LLC Dia Medica Therapeutics Inc. Transaction History
Geode Capital Management, LLC
- $1.07 Trillion
- Q1 2024
A detailed history of Geode Capital Management, LLC transactions in Dia Medica Therapeutics Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 239,235 shares of DMAC stock, worth $669,858. This represents 0.0% of its overall portfolio holdings.
Number of Shares
239,235
Previous 218,778
9.35%
Holding current value
$669,858
Previous $621,000
6.6%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding DMAC
# of Institutions
33Shares Held
3.85MCall Options Held
5.9KPut Options Held
1.4K-
Vanguard Group Inc Valley Forge, PA1.01MShares$2.84 Million0.0% of portfolio
-
First Manhattan CO New York, NY850KShares$2.38 Million0.01% of portfolio
-
Paragon Associates & Paragon Associates Ii Joint Venture Dallas, TX500KShares$1.4 Million2.47% of portfolio
-
Bleichroeder LP New York, NY222KShares$622,4870.19% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA209KShares$586,1290.0% of portfolio
About DiaMedica Therapeutics Inc.
- Ticker DMAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,443,100
- Market Cap $74M
- Description
- DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type...